Hang Seng Biotech Index Surges 4.2% as China Healthcare Sector Attracts Institutional Capital
The Hang Seng Biotech Index rose more than 4% intraday, reflecting broad institutional buying in Hong Kong-listed Chinese healthcare and pharmaceutical stocks.
What’s your take on this? Join the discussion below.
Read the full analysis on market.news
🇨🇳 China Stocks Economic Data biotech pharma healthcare china asia bull-market